All Pathways
Emergency MedicineEmergency

Status Epilepticus Management (AES 2016)

Status Epilepticus Management (AES 2016): Ongoing Seizure Activity → Stabilization Phase (T0) → First-Line: Benzodiazepine (0-5 min) → Seizure Stopped? ...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Ongoing Seizure Activity

    Convulsive seizure >5 min OR recurrent without recovery

    1. Action

      Stabilization Phase (T0)

      ABCs, IV access, glucose check

      • TIME IS CRITICAL - note exact seizure onset
      • Position safely, protect airway
      • Check fingerstick glucose - treat if <60 mg/dL
      • Thiamine 100mg IV if suspected alcohol use/malnutrition
      • Establish IV access (or IO if IV fails)
      1. Action

        First-Line: Benzodiazepine (0-5 min)

        IMMEDIATE benzodiazepine administration

        • IV LORAZEPAM: 0.1 mg/kg (max 4mg), may repeat once
        • IV DIAZEPAM: 0.15 mg/kg (max 10mg), may repeat once
        • IM MIDAZOLAM: 10mg if >40kg, 5mg if 13-40kg (no IV)
        • INTRANASAL MIDAZOLAM: 0.2 mg/kg (max 10mg)
        • RECTAL DIAZEPAM: 0.2-0.5 mg/kg (max 20mg)
        1. Decision

          Seizure Stopped? (at 5-10 min)

          Reassess after first-line therapy

          1. Outcome

            Seizure Terminated

            Continue monitoring, determine cause

          2. Action

            Second-Line Therapy (5-20 min)

            Urgent control medication - choose ONE

            • FOSPHENYTOIN: 20 mg PE/kg IV (max rate 150 mg PE/min)
            • VALPROATE: 40 mg/kg IV (max rate 10 mg/kg/min, max 3000mg)
            • LEVETIRACETAM: 60 mg/kg IV (max 4500mg) over 15 min
            • PHENOBARBITAL: 15 mg/kg IV (if others unavailable)
            • Prepare for intubation if no response
            1. Action

              Concurrent Workup

              Do not delay treatment for workup

              • Labs: BMP, Mg, Ca, CBC, AED levels
              • CT head (after stabilization)
              • LP if infection suspected
              • Toxicology screen
              • Consider MRI when stable
            2. Decision

              Seizure Stopped? (at 20-40 min)

              Reassess after second-line therapy

              1. Action

                Post-SE Monitoring

                ICU admission, EEG monitoring

                • Continuous EEG if available
                • Watch for non-convulsive SE
                • Determine etiology (labs, imaging)
                • Initiate maintenance AED therapy
                1. Outcome

                  Controlled

                  Seizures terminated, begin maintenance therapy

              2. Warning

                REFRACTORY Status Epilepticus

                Seizure continues after adequate 1st & 2nd line therapy

                • Definition: SE persisting after adequate treatment
                • Requires ICU admission
                • Continuous IV anesthetics
                • Intubation required
                1. Action

                  Third-Line: Anesthetic Therapy

                  Continuous IV anesthetics with EEG monitoring

                  • MIDAZOLAM infusion: 0.2 mg/kg bolus, then 0.1-2 mg/kg/hr
                  • PROPOFOL: 1-2 mg/kg bolus, then 20-200 mcg/kg/min
                  • PENTOBARBITAL: 5-15 mg/kg, then 0.5-5 mg/kg/hr
                  • Target: EEG burst suppression or seizure cessation
                  • Maintain 24-48 hours, then slow wean with EEG
                  1. Warning

                    Super-Refractory SE

                    Continues ≥24h despite anesthetic therapy

                    • Ketamine infusion
                    • Immunotherapy if autoimmune suspected
                    • Hypothermia protocol consideration
                    • Epilepsy surgery consultation
                    • Ketogenic diet in select cases
                    1. Outcome

                      Poor Prognosis

                      Prolonged SE associated with high morbidity/mortality

Guideline Source

Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Time-based protocol - document seizure onset time carefully
  • Benzodiazepine doses may need adjustment in elderly/hepatic impairment
  • Second-line agent choice depends on availability and patient factors
  • Refractory SE requires ICU and anesthesia involvement
  • Non-convulsive status epilepticus requires EEG confirmation

Applicable Regions

USEUInternational

EU: Levetiracetam often first choice for second-line therapy

US: Midazolam IM increasingly used prehospital; IV lorazepam preferred in-hospital

International: Phenobarbital may be only option in resource-limited settings

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Status Epilepticus Management (AES 2016)?

The Status Epilepticus Management (AES 2016) is a emergency clinical algorithm for Emergency Medicine. It provides a structured decision tree to guide clinical decision-making, based on Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society.

What guideline is the Status Epilepticus Management (AES 2016) based on?

This algorithm is based on Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society (DOI: 10.1111/epi.13222).

What are the limitations of the Status Epilepticus Management (AES 2016)?

Known limitations include: Time-based protocol - document seizure onset time carefully; Benzodiazepine doses may need adjustment in elderly/hepatic impairment; Second-line agent choice depends on availability and patient factors; Refractory SE requires ICU and anesthesia involvement; Non-convulsive status epilepticus requires EEG confirmation. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Status Epilepticus Management (AES 2016) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free